Discover the multiple sclerosis (MS) patterns that standard brain scans frequently overlook and why these missed indicators ...

Discover the major causes of partial paralysis from stroke and trauma to inflammatory conditions and tumors, plus warning ...

It is also the first drug approved for patients with primary progressive MS (PPMS), where symptoms get worse over time. In an interview with pharmaphorum, Marius Scholtz, country medical lead for ...

Three medications have spasticity reduction as their primary indication ... influence the choice of modality. A progressive disease such as multiple sclerosis might be better managed using ...

Key TakeawaysA new type of AI can help track a person’s multiple sclerosisThe AI correctly judged with 90% accuracy when MS ...

Treatment with masitinib led to lower blood levels of neurofilament light chain (NfL) and pro-inflammatory signaling ...

While his multiple sclerosis is a big part of columnist Ben Hofmeistser's life, it's not his only health concern that deserves attention.

SPMS can cause mobility and balance issues, but you can maintain your independence and safety with these expert-backed home ...

Roche is running three late-stage studies, namely FENhance 1 and 2 trials in relapsing MS, comparing the drug to Sanofi's Aubagio (teriflunomide) and the FENtrepid trial in primary progressive MS ...

Thus, it is a biomarker for MRI activity, perhaps relapses, and likely less so for progression, as the immune system is quite different in progressive MS vs relapsing-remitting MS [RRMS],” Reder ...

Cristcot, a clinical-stage pharmaceutical company advancing innovative therapies for gastrointestinal diseases, today announced the appointment of Jenny Gizzi as Chief Administrative Officer. In this ...

Rachel Accurso defends making the plight of children in Gaza a primary focus on her social media feeds. By Marc Tracy With her pink headband, denim overalls and permanent smile, Ms. Rachel has ...